HADHA and breast cancer: Meta-analysis demonstrated that although there was a consistent decrease in average HADHA expression in patients with a recurring form of breast cancer (summary effect size-0.60, 95% CI-1.44-0.24), the finding was neither statistically significant (p = 0.160) nor homogeneous (I2 = 98.7%) across studies.